FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Latest Updates from the Center for Tobacco Products
FDA Puts Firms Responsible for Esco Bars and Breeze on Notice
Actions are agency’s latest to address flavored, disposable e-cigarettes that appeal to youth.
FDA Denies Marketing of 250+ Flavored and Tobacco-Flavored E-Liquids
Multidisciplinary Scientific Review Finds Products Do Not Meet the Necessary Public Health Standard.
FDA Issues MDOs for Approx. 6,500 Flavored E-cigarette Products
The companies may not market or distribute these products in the U.S., and retailers who sell these illegal products risk FDA enforcement action.
Tobacco Product Marketing Orders
To legally market a new tobacco product, manufacturers must submit an application to FDA and receive a marketing authorization from FDA. When a new tobacco product is granted a marketing order, information is posted online for public awareness. FDA notes that in accordance with a court order, deemed new tobacco products that were on the market as of August 8, 2016 were required to submit an application to FDA by September 9, 2020 or risk enforcement.Learn More About the Latest Marketing Decisions
Actions to Address Recommendations from the Reagan-Udall Foundation Evaluation
At the request of FDA Commissioner Dr. Robert Califf, an independent expert panel facilitated by the Reagan-Udall Foundation (RUF) conducted an operational evaluation of CTP. A final report from the RUF evaluation included 15 recommendations, and in February 2023, CTP published a webpage with detailed plans to address each of the recommendations as quickly as possible. This webpage will be updated routinely to reflect CTP’s latest progress.Learn About CTP’s Actions to Address the RUF Evaluation
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002